Dr. Ross O’Neill

CEO

Neuromod

Ross O’Neill is a biomedical engineer that is passionately committed to delivering brain health through non-invasive neurostimulation. He is the founding CEO of the venture-backed medical devices company Neuromod.  Neuromod has developed and patented LENIRE®, a non-invasive bimodal neuromodulation treatment for chronic tinnitus, a condition that affects 10% of the adult population, commonly known as ‘ringing in the ears’.  Lenire® has been clinically proven to be the leading treatment for chronic tinnitus in two of the largest and longest followed-up clinical trials conducted in the field.   Neuromod are commercialising Lenire® in Europe and pursuing FDA approval for their breakthrough treatment.

All Speakers